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Motor perseveration is
an early sign of
Parkinson’s disease
Article abstract—Perseveration in the generation of random motor behavior
was examined by means of the Vienna perseverance task in groups of de novo
(n  18) and treated (n  18) patients with early PD, and in control subjects
(n  18). In comparison with control subjects, both the de novo and treated
patients with PD were relatively unable to generate random motor sequences,
indicating a decreased ability to switch cortical behavioral programs in PD.
An impairment of random motor generation appears to be a very early fea-
ture of PD.
NEUROLOGY 2001;57:2111–2113
D. Stoffers, MA; H.W. Berendse, MD, PhD; J.B. Deijen, PhD; and E.C. Wolters, MD, PhD
The cognitive deficit in nondemented patients with
PD can be described as an inability to switch cortical
behavioral programs in situations requiring the in-
ternal regulation of behavior, which leads to the per-
severation of the current behavioral program.
Because this type of cognitive disturbance can be
found in the early phases of PD,1 it is tempting to
speculate that such cognitive disturbances may even
precede the first motor deficits. In an animal model
of PD, the 1-methyl-4-phenyl-1,2,3,6-tetrahydro-
pyridine (MPTP)-treated monkey, cognitive distur-
bances are indeed present before any clear motor
disturbances appear.2 Considering the 65% loss of
nigral dopaminergic neurons at the time of clinical
diagnosis, as determined by means of dopamine
transport SPECT,3 a preclinical diagnosis would ex-
tend the time window available for the neuroprotec-
tive strategies that are under development.4
In previous studies, several tasks have been used
to measure the capacity for internal guidance of
behavior. Patients with PD manifest perseverative
behavior on a variety of neuropsychological assess-
ments traditionally believed to reflect frontal lobe
function.5 Most of these tasks, however, provide sub-
jects with implicit rules and logical stimulus–re-
sponse relations, whereas ideally, a task used to
detect disturbances in the internal regulation of be-
havior would have a minimum of external cues,
thereby maximizing the amount of internal (sponta-
neous) regulation of behavior needed to perform the
task. Tasks requiring subjects to generate random
behavior may be better suited to this purpose.
Most research into random behavior in PD has
focused on random verbal generation of either let-
ters6 or numbers.7 Because of the common use of
letters and numbers in everyday life, these tasks are
prone to confounding effects of prior experience with
verbal or numerical tasks. A major pragmatic prob-
lem of random letter or number generation is the
need to record and key the subject’s response, a rela-
tively laborious and potentially error-prone activity.
The Vienna perseverance task is a computerized
version of the pointing task developed by Mitte-
necker and can be used to assess the ability to gener-
ate random motor behavior. Using a manual version
of this task, disturbances in the generation of ran-
dom motor actions have previously been found in
treated patients with early PD.8
In the current study, the Vienna perseverance
task was used to determine whether motor perse-
veration also is present in untreated patients with
early PD. In addition, the effect of dopaminomimetic
treatment on task performance was studied by com-
paring the de novo patients with a group of treated
patients with early PD.
Methods. Subject selection. Groups of nondemented pa-
tients with untreated (n  18) and treated (n  18) idio-
pathic PD were selected from the outpatient clinic for
movement disorders at the Vrije Universiteit Medical Cen-
ter. All patients with PD were diagnosed according to the
United Kingdom Parkinson’s Disease Society Brain Bank
criteria. Eighteen self-declared neurologically healthy sub-
jects served as control subjects. All subjects but one of the
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de novo patients with PD were right-handed. All subjects
were matched for sex, age, and education.
Subject characteristics are listed in table 1. Education
was measured using the Dutch SOI scale, a standard edu-
cational scale. Unified Parkinson’s Disease Rating Scale
motor scores were obtained by a trained neurologist. Dis-
ease duration was calculated on the basis of the patients’
subjective estimate of the time of occurrence of the first
parkinsonian symptoms. Treated patients were tested dur-
ing their normal regime of antiparkinsonian medication
(i.e., a dopamine agonist, L-dopa, or a combination of the
two). In case of motor response fluctuations, patients were
tested during their on period. None of the patients or con-
trol subjects were using benzodiazepines, antipsychotics,
or stimulants.
Vienna perseveration task. The Vienna perseveration
task is part of the Vienna test system (Dr. G. Shuhfried
Ges.m.b.H, Mödling, Switzerland). Seated in front of a 17-
inch monitor, subjects were instructed to randomly press
nine circles displayed on screen with a light pen, avoiding
the use of systematic or repetitive strategies. The task
consisted of 210 consecutive presses that had to be per-
formed at the constant rhythm of a short “bleep” that was
offered 64 times per minute. Task duration was approxi-
mately 4 minutes, depending on the number of omissions.
Each subject was given a practice run (duration approxi-
mately 30 seconds) to get accustomed to the instrumenta-
tion and the actual test procedure.
Data analysis. Perseverative behavior was assessed by
determining the relative redundancies of the first and sec-
ond order. Relative redundancy of the first order (R1) is a
measure of the preference for individual circles. R1 can be
calculated by relating the observed degree of randomness
[H (X)] to the maximum degree of randomness [Hmax (X)]:
R1 X	 
Hmax X	  H X	
Hmax X	
It reaches a minimum when the tapped circles are
evenly distributed.
Redundancy of the second order expresses the probabil-
ity with which circle Y will be selected after a tap on circle
X. By dividing the observed value of this variable by its
maximum value, the relative redundancy of the second
order (R2) is obtained:
R2 X, Y	 
H X:Y	
Hmax X:Y	
The lower the preference for certain combinations of
circles, the more improbable the prediction of variable Y by
variable X, and thus the smaller the R2. At an equal dis-
tribution of the 81 possible combinations of circles, R2  0.
Statistical analysis comprised two-tailed univariate
analysis of variance of log 10 transformed data at a signif-
icance level of 0.05 and post-hoc analysis of individual
group differences by means of Bonferroni (equal variances)
or Tamhane’s T2 (unequal variances). An estimate of effect
size (ES) was based on the linearly independent pairwise
comparison among the estimated marginal means.
Results. Means and SDs of motor perseveration scores
are listed in table 2. No significant differences were found
with respect to the relative redundancy of the first order,
indicating no differences in relative preference for certain
circles between the three groups. A group difference was
found with respect to the relative redundancy of the second
order (F[2,51]  8.13; p  0.001; ES  0.49). Post-hoc
analysis of group differences revealed a deficit to generate
random sequences as expressed by the index of relative
redundancy of the second order in the de novo group rela-
tive to the control group (p  0.001). Similarly, the average
relative redundancy of the second order in the group of
treated patients with PD was higher than that of the con-
trol group (p  0.012). No significant differences in relative
redundancy of the second order between the de novo and
treated patients were found. The number of omissions was
equal across all groups. Based on these data, an estimate
of the diagnostic value of the Vienna perseverance task,
using the criterion of maximization of the sum of sensitiv-
ity and specificity, yielded a sensitivity of 67% at a speci-
ficity of 99% for correctly classifying the patients with de
novo PD.
Table 1 Subject characteristics
Characteristics
Control
subjects, n  18
Patients with de novo PD,
n  18
Patients with treated PD,
n  18
Sex, M/F 14/4 14/4 14/4
Age, y, mean  SD 56  6.2 58  9.4 60  8.3
Education, SOI, mean  SD 5.9  1.3 6.0  1.1 6.0  1.3
UPDRS motor score, mean  SD 0.4  0.8 9.8  2.8 12.6  8.8
Disease duration, y, mean  SD NA 1.8  1.1 3.9  1.8*
Hoehn and Yahr stage, I/II NA 16/2 13/5
* Different from patients with de novo PD (two-tailed, p  0.000).
SOI  Standaard Onderwijs Indeling; NA  not applicable.











R1 (%) 0.79  0.43 1.14  1.06 0.93  1.22
R2 (%) 18.92  1.79 29.99  12.91* 26.38  8.12†
* Different from control subjects (two-tailed, p  0.001).
† Different from control subjects (two-tailed, p  0.012).
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Discussion. We found an impairment in generat-
ing random motor sequences in early-stage treated
as well as in untreated patients with PD, confirming
previous observations.6-8 Our study of random motor
behavior in PD is of note because we found perse-
verative tendencies even in patients with early, un-
treated PD.
The average performance of the treated patients
was not better than that of the untreated patients.
Although the effect of dopaminomimetics on random
motor generation ideally should be determined using
a longitudinal approach, we believe a tentative con-
clusion can be drawn from the current data. Taking
into consideration the somewhat longer disease du-
ration in the treated patients, dopaminomimetics
would appear to have little, if any, effect on random
motor generation.
The generation of random behavior is thought to
involve holding information on line, suppression of
habitual responses, generation of internally driven
responses, monitoring of responses, and modification
or switching of production strategies,9 all of which
are attention demanding and likely to involve the
so-called supervisory attentional system (SAS). In
particular, deficits concerning modification or
switching of production strategies and internally
driven response generation are thought to be respon-
sible for perseverative tendencies and other cognitive
deficits in PD and may therefore reflect dysfunction
of the SAS.10 Because of the complete absence of
external stimuli to guide selection of the next re-
sponse and the need for novelty, in the sense that
responses are required to lack any systematic or re-
petitive strategies, random motor generation ap-
pears to be an ideal task for studying dysfunction of
the SAS in PD.
Our data, obtained in selected groups of patients
with de novo PD and control subjects, suggest that
an impairment of random motor generation may be
potentially useful as an early diagnostic marker. The
ease of administration and the objectivity in scoring
and interpretation of the Vienna perseverance task,
as well as its short duration, further add to the po-
tential usefulness of this task as (part of) a screening
test for PD. Future prospective studies in patients
with PD, as well as comparative studies including
patients with atypical parkinsonian syndromes, are
necessary to determine more clearly the early diag-
nostic value of the Vienna perseverance task in PD.
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